Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Regulating cell death in hair follicles can help prevent hair loss and promote hair growth.

Short Anagen Syndrome causes persistently short hair and increased shedding, usually improving after puberty.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Low-level light therapy, possibly combined with other treatments, may become a leading hair loss treatment, while hirsutism often worsens with age and lacks preventive options.

Young rats are better for testing hair loss treatments after chemotherapy.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

The review suggests limited treatments for common hair loss conditions, with potential for future improvements.

Mice hair growth patterns get more complex with age and can change with events like pregnancy or injury.

Children's hair grows in different types from before birth through puberty, with growth rates and characteristics varying by age, sex, and race.

Human hair follicles switch between active and resting phases unpredictably.

Immune cells affect hair growth and could lead to new hair loss treatments.

Naproxen is not the cause of hair loss in a child; it's due to a toxic event with expected hair regrowth.

The document concluded that cyproterone acetate and minoxidil are effective for female hair loss, and a supportive doctor-patient relationship is important.

Hair growth is influenced by hormones and goes through different phases; androgens can both promote and inhibit hair growth depending on the body area.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Telogen effluvium is a common hair loss condition requiring careful diagnosis and treatment.

Male-pattern hair loss is normal, often involves hormone effects on hair follicles, and can be treated with medication or surgery, but new treatments are being researched.

Chronic exposure to sunlight may worsen male pattern baldness and protecting the scalp from the sun could slow it down.

Hair loss in children is diagnosed and treated differently than in adults, with different common causes and a focus on less invasive methods.

Some children are born with unusually short, fine hair because their hair growth phase is short, but this often gets better by itself during puberty.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

The document says that there are treatments for hair and nail diseases.

Women with certain types of hair loss may have low iron levels.

Chemotherapy can cause rapid, extensive hair loss, with patterns varying between individuals.

Hominis Placenta helps hair grow back by increasing cell growth and a specific growth factor.